Skip to main content
Equibles

STATE STREET CORP

Position in DSGN — Design Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$10,653,117
+$3,635,239 QoQ
Shares Held
736,221
+11.6% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 22% Shared 0% None 78%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. DSGN ranks #179 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in DSGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,653,117 736,221
2026-03-31 $7,017,878 659,575
2025-12-31 $6,074,825 647,636
2025-09-30 $4,777,009 634,397
2025-06-30 $2,423,744 719,212
2025-03-31 $2,756,325 714,074
2024-12-31 $4,462,878 723,319
2024-09-30 $3,716,643 690,826
2024-06-30 $2,329,667 695,423
2024-03-31 $2,816,913 698,986
2023-12-31 $1,842,343 695,224
2023-09-30 $1,634,826 692,723
2023-06-30 $3,692,020 586,035
2023-03-31 $4,105,516 711,528
2022-12-31 $31,164,339 3,037,460
2022-09-30 $15,206,321 909,469
2022-06-30 $6,296,934 449,781
2022-03-31 $6,517,187 403,541
2021-12-31 $7,327,808 342,261
2021-09-30 $3,108,521 211,608
2021-06-30 $3,741,090 188,089